Literature DB >> 30528278

Meta-Analysis of Prevalence and Short-Term Prognosis of Hemodynamically Unstable Patients With Symptomatic Acute Pulmonary Embolism.

Carlos Andrés Quezada1, Behnood Bikdeli2, Deisy Barrios1, Esther Barbero1, Diana Chiluiza1, Alfonso Muriel3, Franco Casazza4, Manuel Monreal5, Roger D Yusen6, David Jiménez7.   

Abstract

There remains limited information about the prevalence and outcomes of hemodynamic unstable patients with acute pulmonary embolism (PE). We performed a systematic review and meta-analysis of prospective registries that enrolled patients with acute PE to assess the prevalence and prognostic significance of hemodynamic instability for the primary outcome of short-term all-cause mortality, and the secondary outcome of short-term PE-related mortality. We also assessed the association between use of thrombolytic therapy versus no use and short-term outcomes in the subgroup of unstable patients. We used a random-effects model to pool study results; and I2 testing to assess for heterogeneity. The authors' search retrieved 4 studies that enrolled 1,574 patients with unstable PE (1,574/40,363; 3.9%; 95% confidence interval [CI], 3.7% to 4.1%). Hemodynamic instability had a significant association with short-term all-cause mortality (odds ratio [OR], 5.9; 95% CI, 2.7 to 13.0; I2 = 94%), and with PE-related death (OR, 8.2; 95% CI, 3.4 to 19.7). In unstable patients, thrombolytic therapy was associated with reduced odds of short-term all-cause mortality (OR, 0.69; 95% CI, 0.49 to 0.95), and PE-related death (OR, 0.66; 95% CI, 0.45 to 0.97). In conclusion, hemodynamic instability significantly increased the risk of death shortly after PE diagnosis. Use of thrombolytic therapy was associated with significantly reduced short-term mortality.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30528278     DOI: 10.1016/j.amjcard.2018.11.009

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  Thrombolysis in hemodynamically unstable patients: still underused: a review based on multicenter prospective registries on acute pulmonary embolism.

Authors:  Marco Zuin; Gianluca Rigatelli; Giovanni Zuliani; Pietro Zonzin; Daggubati Ramesh; Loris Roncon
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

Review 2.  Thrombolytic therapy in acute venous thromboembolism.

Authors:  Thita Chiasakul; Kenneth A Bauer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 3.  Risk stratification for clinical severity of pulmonary embolism in patients with cancer: a narrative review and MASCC clinical guidance for daily care.

Authors:  Diego Muñoz-Guglielmetti; Tim Cooksley; Shin Ahn; Carmen Beato; Mario Aramberri; Carmen Escalante; Carme Font
Journal:  Support Care Cancer       Date:  2022-05-17       Impact factor: 3.359

Review 4.  Risk Stratification in Patients with Acute Pulmonary Embolism: Current Evidence and Perspectives.

Authors:  Antonio Leidi; Stijn Bex; Marc Righini; Amandine Berner; Olivier Grosgurin; Christophe Marti
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

Review 5.  Contemporary Catheter-Based Treatment Options for Management of Acute Pulmonary Embolism.

Authors:  Maninder Singh; Irfan Shafi; Parth Rali; Joseph Panaro; Vladimir Lakhter; Riyaz Bashir
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-05-12

6.  Implications of Abnormal Troponin Levels With Normal Right Ventricular Function in Normotensive Patients With Acute Pulmonary Embolism.

Authors:  Rosa Mirambeaux; Raphael Le Mao; Alfonso Muriel; Beatriz Pintado; Andrea Pérez; Diurbis Velasco; José Luis Lobo; Deisy Barrios; Raquel Morillo; Behnood Bikdeli; David Jiménez
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

7.  Thrombolytic Therapy in Octogenarians with Acute Pulmonary Embolism.

Authors:  Ahmet Zengin; Mehmet Baran Karataş; Yiğit Çanga; Özge Güzelburç; Nizamettin Selçuk Yelgeç; Ayşe Emre
Journal:  Arq Bras Cardiol       Date:  2022-01       Impact factor: 2.000

8.  Thrombolysis in Pulmonary Embolism: Octagenarians Deserve More Attention!

Authors:  Hugo Hyung Bok Yoo
Journal:  Arq Bras Cardiol       Date:  2022-01       Impact factor: 2.000

9.  American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.

Authors:  Thomas L Ortel; Ignacio Neumann; Walter Ageno; Rebecca Beyth; Nathan P Clark; Adam Cuker; Barbara A Hutten; Michael R Jaff; Veena Manja; Sam Schulman; Caitlin Thurston; Suresh Vedantham; Peter Verhamme; Daniel M Witt; Ivan D Florez; Ariel Izcovich; Robby Nieuwlaat; Stephanie Ross; Holger J Schünemann; Wojtek Wiercioch; Yuan Zhang; Yuqing Zhang
Journal:  Blood Adv       Date:  2020-10-13

10.  Anticoagulation in pulmonary arterial hypertension: a decision analysis.

Authors:  Arun Jose; Mark H Eckman; Jean M Elwing
Journal:  Pulm Circ       Date:  2019-12-23       Impact factor: 3.017

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.